Prithviraj Bose

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Prithviraj Bose
Mar 19, 2025, 17:38 | Blog
Naveen Pemmaraju: An important evening of filming to help raise awareness in MPN clinical research
Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at…
Mar 11, 2025, 07:54 | Science
Raajit Rampal: Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis
Raajit Rampal, an Associate Member at the Memorial Sloan Kettering Cancer Center, recently shared on…
Dec 16, 2024, 18:10 | Insight
Cellenkos Presented Results of Phase 1b Data for CK0804 T-Regulatory Cell Therapy in Myelofibrosis at ASH 2024
Innovative Cellular Therapy Demonstrated Safety and Potential Clinical Benefit at ASH 2024 Cellenkos, a clinical-stage…
Dec 8, 2024, 06:21 | Insight
Understanding and treating myelofibrosis
Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…
Dec 4, 2024, 20:32 | Insight
Naveen Pemmaraju: Add-On Therapy with CK0804 in Myelofibrosis Patients with Suboptimal Response to Ruxolitinib
Naveen Pemmaraju shared a post on X: "Highlighting the wonderful work of Dr Lucia Masarova. Prelim/early…
Dec 2, 2024, 17:59 | Insight
Naveen Pemmaraju: Pre-clinical Investigation of Tasquinimod for AML Following Myeloproliferative Neoplasm
Naveen Pemmaraju shared a post on X: "Check out our novel Myeloproliferative neoplasm abstract for ASH…
Aug 19, 2024, 10:38 | Insight
Hagop Kantarjian: All you need to know about the latest JAK inhibitor to be approved for myelofibrosis
Hagop Kantarjian shared a post on X about a recent paper by Prithviraj Bose published…
Aug 1, 2024, 14:55 | Blog
Naveen Pemmaraju: Honored to be a featured MPN faculty speaker for upcoming Research Town Hall on Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: "Honored to be a featured MPN faculty speaker…
Jul 31, 2024, 00:07 | Insight
Important dataset that informs current practice for MF
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X: "Important dataset that…
Jun 17, 2024, 07:05 | Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 16, 2024, 12:58 | Insight
Prithviraj Bose: Encouraging to see JAK2 V617F VAF reduction correlate with improved EFS
Prithviraj Bose, Professor of Leukemia at MD Anderson Cancer Centre, shared on X: "Encouraging to…
May 25, 2024, 09:12 | Insight
Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24
Sankalp Arora, Heme/Onc fellow at MD Anderson Cancer Center, shared on X/Twitter: "The ASCO24 countdown begins!…
Sep 25, 2023, 16:57 | Insight
Lucia Masarova: Disease modification time in Polycythemia Vera is here!
Lucia Masarova, oncology specialist in Houston, TX, shared a post by Naveen Pemmaraju, on Twitter: "Disease…
All: 13 Posts: 1 - 100
Special Coverage